Details of the Optogenetic System
General Information of This Optogenetic System (OS) | ||||||
---|---|---|---|---|---|---|
OS ID |
OS00029
|
|||||
OS Name |
Light inducible nuclear translocation and dimerization system
(LINTAD)
|
[1] | ||||
Photoreceptor (PR) |
|
|||||
Complementary Protein | Cryptochrome-interacting basic-helix-loop-helix 1 (CIB1/CIBN) | |||||
Cofactor | Flavin adenine dinucleotide (FAD) | |||||
Controlled Protein | Fusion protein | LexA activation domain | ||||
Recruited protein | Transcription regulator LexA | |||||
OS Application Information (1) | ||||||
---|---|---|---|---|---|---|
Mechanism of Action | CRY2-CIB1 heterodimerization | [ 1] | ||||
Controlled Signal Pathway | Gene expression activation | |||||
Effect | Activation | |||||
Application | Control transcription in CAR T cell for cancer therapy | |||||
Note | LexA-VP is an orthogonal transcription factor | |||||
Light Information | Activation Wavelength | 460 nm | ||||
Process | Reversible | |||||
Deactivation Wavelength | Dark | |||||
Activation Time | Seconds | |||||
Deactivation Time | Minutes | |||||
Light Intensity | 5 milliwatts per square centimeter | |||||
Expression Information | Expression Method | Transduction and Transfection | ||||
Cell Lines | CAR T cells | |||||